Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zymeworks Q2 2024 GAAP EPS $(0.49) Misses $0.07 Estimate, Sales $19.243M Miss $48.860M Estimate

Author: Benzinga Newsdesk | August 01, 2024 04:40pm
Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $0.07 by 800 percent. This is a 35.53 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $19.243 million which missed the analyst consensus estimate of $48.860 million by 60.62 percent. This is a 174.82 percent increase over sales of $7.002 million the same period last year.

Posted In: ZYME


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist